BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16053339)

  • 1. Calcium dobesilate in the treatment of diabetic retinopathy.
    Garay RP; Hannaert P; Chiavaroli C
    Treat Endocrinol; 2005; 4(4):221-32. PubMed ID: 16053339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina.
    Szabo ME; Haines D; Garay E; Chiavaroli C; Farine JC; Hannaert P; Berta A; Garay RP
    Eur J Pharmacol; 2001 Oct; 428(2):277-86. PubMed ID: 11675046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P; Farine JC; Barras JP
    Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
    Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
    Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.
    Zhang X; Liu W; Wu S; Jin J; Li W; Wang N
    Sci China Life Sci; 2015 Jan; 58(1):101-7. PubMed ID: 25528255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C; Koerner F
    Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of calcium dobesilate in diabetic retinopathy. A double-blind clinical investigation.
    Salama Benarroch I; Nano H; Pérez H; Elizalde F; Bisceglia H; Salama A
    Ophthalmologica; 1977; 174(1):47-51. PubMed ID: 322009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of calcium dobesilate on nonproliferative diabetic retinopathy: a controlled study.
    Stamper RL; Smith ME; Aronson SB; Cavender JC; Cleasby GW; Fung WE; Becker B
    Ophthalmology; 1978 Jun; 85(6):594-606. PubMed ID: 353623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Dobesilate and Micro-vascular diseases.
    Liu J; Li S; Sun D
    Life Sci; 2019 Mar; 221():348-353. PubMed ID: 30769115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model.
    Voabil P; Liberal J; Leal EC; Bauer J; Cunha-Vaz J; Santiago AR; Ambrósio AF
    Ophthalmic Res; 2017; 58(3):150-161. PubMed ID: 28793297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy.
    Chung HK; Choi SM; Ahn BO; Kwak HH; Kim JH; Kim WB
    Arzneimittelforschung; 2005; 55(10):573-80. PubMed ID: 16294503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E; Ganado P; Sanz M; Zeini M; Ruiz E; Triviño A; Ramírez AI; Salazar JJ; Ramírez JM; Rojas B; Hoz Rd; Tejerina T
    Diabetes Metab Res Rev; 2005; 21(2):132-42. PubMed ID: 15386814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
    Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
    Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
    Benarroch IS; Brodsky M; Rubinstein A; Viggiano C; Salama EA
    Ophthalmic Res; 1985; 17(3):131-8. PubMed ID: 4011126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
    Larsen HW; Sander E; Hoppe R
    Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
    Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium dobesilate prevents the oxidative stress and inflammation induced by diabetes in the retina of db/db mice.
    Bogdanov P; Solà-Adell C; Hernández C; García-Ramírez M; Sampedro J; Simó-Servat O; Valeri M; Pasquali C; Simó R
    J Diabetes Complications; 2017 Oct; 31(10):1481-1490. PubMed ID: 28847447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.